Trial intelligence / Profile preview

VITA-D: Cholecalciferol substitution in vitamin D deficient kidney transplant recipients

2008-002807-21Phase 3Completed

Sponsor
Medical University of Vienna, Division of Nephrology and Dialysis
Start
Sep 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in Vitamin D deficiency (VDD) and Kidney allograft status (RTx) comparing Cholecalciferol substitution with Placebo (2 arms). Primary endpoint: Primary immunologic effects. Started Sep 2008; status: completed.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)Kidney allograft status (RTx)

Beyond the preview

Go deeper on 2008-002807-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002807-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call